Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Melanie K. Bothe"'
Autor:
Melanie K. Bothe, Dirk Berressem, Rosa Abele, Heinrich Topp, Birgit Alteheld, Peter Stehle, Johannes Harleman, Martin Westphal, John F. Stover
Publikováno v:
Clinical Nutrition Experimental, Vol 25, Iss , Pp 11-19 (2019)
Summary: Background & aims: Administration of glutamine in patients with renal dysfunction is considered to be potentially adverse. In a rat model of moderate kidney dysfunction dose-dependent effects of intravenous alanyl-glutamine infusion on possi
Externí odkaz:
https://doaj.org/article/842d4d9c520a4b0d904c5f233efae929
Autor:
Melanie K. Bothe, Rosa Abele, Heinrich Topp, Johannes Harleman, Martin Westphal, John F. Stover
Publikováno v:
Clinical Nutrition Experimental, Vol 21, Iss , Pp 9-17 (2018)
Summary: Background & aims: Administration of glutamine in patients with liver failure is thought to possibly increase blood ammonia levels, thereby contributing to hepatic encephalopathy. In a rat model of moderate liver dysfunction with elevated pl
Externí odkaz:
https://doaj.org/article/1e69b765751b4b95bb796d60bf3643c1
Autor:
Melanie K. Bothe, Lida A. Quinchia, Getachew Assegehegn, Crispulo Gallegos-Montes, Edmundo Brito de la Fuente, Johannes Harleman
Publikováno v:
Clinical Nutrition Experimental, Vol 8, Iss C, Pp 25-33 (2016)
Background: The compliance of lipid admixtures to physical emulsion stability parameters is extremely important to ensure the safety of patients. For example, admixtures containing a percentage of fat globules larger than 5 μm in diameter (concept k
Externí odkaz:
https://doaj.org/article/276c3277c41d452eae04eb4c43896bd6
Publikováno v:
Drug and Chemical Toxicology. :1-6
Autor:
Melanie K Bothe
Publikováno v:
Toxicology: Current Research. 4:1-5
Autor:
John F. Stover, Martin Westphal, Johannes Harleman, Rosa Abele, Melanie K. Bothe, Heinrich Topp
Publikováno v:
Clinical Nutrition Experimental, Vol 21, Iss, Pp 9-17 (2018)
Summary: Background & aims: Administration of glutamine in patients with liver failure is thought to possibly increase blood ammonia levels, thereby contributing to hepatic encephalopathy. In a rat model of moderate liver dysfunction with elevated pl
Publikováno v:
International journal of toxicology. 39(1)
The alkylating agent busulfan is used in conditioning treatment of chronic myelogenous or granulocytic leukemia prior to stem cell transplantations. Its cytotoxic activity results in primary damage or destruction of hematopoietic cells. While the tox
Autor:
Edmundo Brito De La Fuente, Getachew Assegehegn, Crispulo Gallegos-Montes, Melanie K. Bothe, Lida A. Quinchia, Johannes Harleman
Publikováno v:
Clinical Nutrition Experimental, Vol 8, Iss C, Pp 25-33 (2016)
Summary Background The compliance of lipid admixtures to physical emulsion stability parameters is extremely important to ensure the safety of patients. For example, admixtures containing a percentage of fat globules larger than 5 μm in diameter (co
Autor:
Virginie Roger, Johannes Harleman, Jean-Christophe Queudot, Christoph Meyer, Udo Mueller, Melanie K. Bothe, Martin Westphal
Publikováno v:
The Journal of toxicological sciences. 42(6)
Plasma amino acid level changes occur in mild, moderate and severe stages of liver injury in human patients. In animal models, however, data are mainly restricted to severe liver injury models in rats. Here we present the characterization of a rat mo
Autor:
John F Stover, Melanie K Bothe
Publikováno v:
Future Neurology. 9:197-209
ABSTRACT: Traumatic brain injury is typically characterized by the primary injury initiating a cascade of pathologic changes that then lead to secondary brain injury. Secondary brain injury is amenable to different therapeutic options. Monitoring of